Stock Scorecard

Stock Summary for Abbott Laboratories (ABT) - $96.00 as of 9/28/2023 6:01:59 PM EST

Total Score

7 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ABT

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ABT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ABT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for ABT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for ABT

Abbott Laboratories Unusual Options Activity - Abbott Laboratories ( NYSE:ABT ) 9/28/2023 6:48:00 PM
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle 9/28/2023 4:22:00 PM
The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy 9/28/2023 11:37:00 AM
Personalized Nutrition Market size to increase by USD 6.47 billion between 2022 to 2027. Abbott Laboratories, Amway ... - PR Newswire 9/28/2023 3:35:00 AM
Cataract Surgery Devices And Equipment Market Analysis 2023-2027: Projected Market Size, Key Drivers, And Major Segments As Per The Business Research Company's Cataract Surgery Devices And Equipment Global Market Report 2023 9/26/2023 3:30:00 PM
Prestige Consumer ( PBH ) Stock Rallies 20% in a Year: Here's Why 9/26/2023 1:56:00 PM
Here's Why Investors Should Invest in Abbott ( ABT ) Stock Now 9/26/2023 12:48:00 PM
5 Dividend Aristocrats to Buy as Things Look Dicey for Wall Street 9/26/2023 12:03:00 PM
Cardiovascular Information System (CVIS) Market size to grow by USD 582.77 million from 2022-2027| Abbott ... - PR Newswire 9/25/2023 11:15:00 PM
Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus ... - PR Newswire 9/25/2023 9:15:00 PM

Financial Details for ABT

Company Overview
Ticker ABT
Company Name Abbott Laboratories
Country USA
Description Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2023
Next Earnings Date 10/17/2023

Stock Price History
Last Day Price 96.00
Last Day Price Updated 9/28/2023 6:01:59 PM EST
Last Day Volume 0
Average Daily Volume 4,260,487
52-Week High 115.83
52-Week Low 91.93
Last Price to 52 Week Low 4.43 %

Valuation Measures
Trailing PE 32.60
Industry PE 43.96
Sector PE 47.89
5-Year Average PE 30.35
Free Cash Flow Ratio 20.43
Industry Free Cash Flow Ratio 12.58
Sector Free Cash Flow Ratio 31.90
Current Ratio Most Recent Quarter 1.64
Total Cash Per Share 4.70
Book Value Per Share Most Recent Quarter 21.42
Price to Book Ratio 5.44
Industry Price to Book Ratio 4.72
Sector Price to Book Ratio 21.80
Price to Sales Ratio Twelve Trailing Months 4.20
Industry Price to Sales Ratio Twelve Trailing Months 5.61
Sector Price to Sales Ratio Twelve Trailing Months 3.72

Share Statistics
Total Shares Outstanding 1,735,360,000
Market Capitalization 166,594,560,000
Institutional Ownership N/A

Dividends
Ex-Dividend Date 10/12/2023
Last Dividend Amount 0.51
Current Dividend Amount 0.51
Dividend Aristocrat? False
Trailing Annual Dividend Rate 2.00
Trailing Annual Dividend Yield 2.12 %
5-Year Dividend Payments Count 21
Dividend Payout Ratio 68.26 %

Income Statement
Quarterly Earnings Growth YOY -31.60 %
Annual Earnings Growth -1.95 %
Reported EPS 12 Trailing Months 2.93
Reported EPS Past Year 2.11
Reported EPS Prior Year 5.34
Net Income Twelve Trailing Months 5,161,000,000
Net Income Past Year 6,933,000,000
Net Income Prior Year 7,071,000,000
Quarterly Revenue Growth YOY -11.40 %
5-Year Revenue Growth 9.88 %

Balance Sheet
Total Cash Most Recent Quarter 8,155,000,000
Total Cash Past Year 10,170,000,000
Total Cash Prior Year 10,249,000,000
Net Cash Position Most Recent Quarter -8,691,000,000
Net Cash Position Past Year -6,603,000,000
Long Term Debt Past Year 16,773,000,000
Long Term Debt Prior Year 18,050,000,000
Total Debt Most Recent Quarter 16,846,000,000
Equity to Debt Ratio Past Year 0.69
Equity to Debt Ratio Most Recent Quarter 0.69
Total Stockholder Equity Past Year 36,686,000,000
Total Stockholder Equity Prior Year 35,802,000,000
Total Stockholder Equity Most Recent Quarter 37,174,000,000

Options
Put/Call Ratio 0.18
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -2.03
MACD Signal -1.59
20-Day Bollinger Lower Band 96.72
20-Day Bollinger Middle Band 105.04
20-Day Bollinger Upper Band 113.36
Beta 0.67
RSI 26.67
50-Day SMA 104.85
200-Day SMA 105.23

System
Modified 9/28/2023 4:22:07 PM EST